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Abstract
Background. The aims of the study were to examine the 
effects of a multidimensional rehabilitation program 
on cancer-related fatigue, to examine concurrent pre-
dictors of fatigue, and to investigate whether change in 
fatigue over time was associated with change in predic-
tors.
 Methods. Sample: 72 cancer survivors with dif-
ferent diagnoses. Setting: rehabilitation center. Inter-
vention: 15-week rehabilitation program. Measures: 
Fatigue (Multidimensional Fatigue Inventory), demo-
graphic and disease/treatment-related variables, body 
composition (bioelectrical impedance), exercise capac-
ity (symptom-limited bicycle ergometry), muscle force 
(handheld dynamometry), physical and psychological 
symptom distress (Rotterdam Symptom Check List), 
experienced physical and psychological functioning 
(RAND- 36), and self-efficacy (General-Self-Efficacy 
Scale, Dutch version). Measurements were performed 
before (T0) and after rehabilitation (T1).
Results. At T1 (n = 56), significant improvements in 
fatigue were found, with effect sizes varying from −0.35 
to −0.78. At T0, the different dimensions of fatigue were 
predicted by different physical and psychological vari-
ables. Explained variance of change in fatigue varied 
from 42%–58% and was associated with pre-existing 
fatigue and with change in physical functioning, role 
functioning due to physical problems, psychological 
functioning, and physical symptoms distress.
 Conclusions. Within this selected group of patients 
we found that (a) rehabilitation is effective in reducing 
fatigue, (b) both physical and psychological param-
eters predicted different dimensions of fatigue at base-
line, and (c) change in fatigue was mainly associated 
with change in physical parameters. The Oncologist 
2006;11:184–196
Introduction
Fatigue is one of the most frequently reported complaints in 
cancer patients and survivors. Fatigue is a subjective con-
dition, commonly defined as a patient’s feeling of lack of 
energy, weariness, or as “a persistent, subjective sense of 
tiredness related to cancer that interferes with usual func-
tioning” [1]. In contrast to the tiredness sometimes felt by 
a healthy individual, cancer-related fatigue is perceived as 
being of greater magnitude, disproportionate to activity or 
exertion, and not relieved by rest [2]. Some cancer patients 
perceive fatigue as a psychological alteration, whereas 
others perceive fatigue as the most distressing symptom 
This material is protected by U.S. Copyright law. 
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because of its impairing consequences on their physical 
activity level [3]. Whether fatigue has more psychological, 
physical, or combined consequences, patients generally 
associate fatigue with a high level of impairment in daily 
living and, therefore, a low quality of life [4].
The extent of the problem of cancer-related fatigue in 
the short and longer term is unclear. About 70% of people 
with cancer report feelings of fatigue during radiotherapy 
[5], chemotherapy [6], bone marrow transplantation [7, 8], 
or after surgery [9]. However, a minimal increase in fatigue 
after radiotherapy was also reported [10]. That fatigue 
may be a serious problem in the longer term is shown by 
the reported percentage of up to 30% of cancer survivors 
who experience fatigue for years after the end of their treat-
ment [4, 11]. Whatever the percentages are, the problem of 
fatigue is still underestimated by oncologists [12].
The determinants of the onset and persistence of fatigue 
are still poorly understood [13]. Cancer-related fatigue is 
attributed to a variety of disease-related and treatment-
related factors such as the cancer itself, anemia [12, 14, 
15], cytokines, nutritional and fluid imbalances, etc. [3, 5]. 
Cancer-related fatigue is associated with treatment-related 
physiological and psychological mechanisms. Physiologi-
cal mechanisms include the occurrence of reduced aerobic 
capacity, physical performance, and muscle wasting as a 
side effect of anticancer treatment [3, 4, 16]. These physi-
ological mechanisms may be aggravated by the inactiv-
ity resulting from the advice of bed rest and to downscale 
activities. A low activity pattern may lead to more muscle 
deconditioning and disuse atrophy [17], which in turn may 
aggravate the feelings of fatigue [18]. In fact, a vicious cir-
cle may occur and account for the persistence of fatigue in 
the longer term [3, 16].
Psychological factors are related to the onset and the 
persistence of fatigue in cancer patients. Over time, the dif-
ferent stages and phases of cancer, varying from diagnosis 
to treatment and post-treatment, have been associated with 
psychological symptoms such as anxiety and depression 
[14, 19], reduced self-efficacy [20], sleep disorders, distress 
[21], and difficulty coping [3]. However, whether fatigue is 
a cause or an effect of these factors is still unknown [22]. 
There are even studies that suggest that there is no strong 
cause-and-effect relationship between fatigue and, for 
example, depression [23].
Although the exact determinants of cancer-related 
fatigue need more scientific research, its multifactorial 
nature seems to be generally acknowledged [22]. There-
fore, a diversity of psychological and physical interventions 
that have the potential to reduce cancer-related fatigue have 
been described. The described psychological interventions 
were aimed at reducing fatigue in cancer patients through 
facilitating coping with the disease and improving qual-
ity of life [21, 24, 25]. Since fatigue seems to be associated 
with a physical and a functional component, a growing 
number of studies reported on the effectiveness of physical 
training, that is, exercise training [26–29]. Exercise train-
ing is reported to be beneficial for cancer patients because 
it is aimed at improving functional capacity and muscle 
strength and at decreasing cancer-related fatigue, which 
may in turn contribute to a better overall quality of life [7, 
29–32].
For the present study, because of the associations found 
between cancer-related fatigue and physical and psycho-
logical factors, we acknowledged fatigue as a problem with 
different dimensions, as previously proposed by others 
[33]. Accordingly, we theorized that such a multidimen-
sional problem might require a multidimensional interven-
tion that included physical and psychological components. 
Therefore, we developed a multidimensional rehabilitation 
program that includes exercise, sports and games, infor-
mation, and psychoeducation. We first hypothesized that 
the multidimensional rehabilitation program would have 
beneficial effects on fatigue. Secondly, we hypothesized 
that different physical and psychological variables would 
be associated with different domains of fatigue and that 
decreased fatigue after the program would be associated 
with changes in both physical and psychological variables.
Patients and Methods
Sample
Patients were eligible for the study if they met the follow-
ing criteria: age ≥18 years; referred by hospital special-
ists or general practitioners; last cancer-related treatment 
>3 months ago; estimated life expectancy ≥1 year, and an 
indication for rehabilitation. The latter meant a minimum 
of three positive findings on the following questions, as 
judged by a physician:
(a)  Physical complaints like aching muscles, problems 
with coordination, headache, nausea, heart 
palpitations, shortness of breath;
(b)  Reduced physical capacity compared with before 
the illness (for example, less able to walk or cycle);
(c)  Psychological problems like increased anxiety 
level, depression, uncertainty, lack of energy, or 
nervousness;
(d)  Increased levels of fatigue;
(e)  Sleep disturbances;
(f)  Problems in coping with reduced physical and 
psychosocial functioning due to cancer.
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Patients were not included if they met one of the fol-
lowing criteria: (a) a very low level of activity according to 
the classification of Winningham [31], for example, <50% 
of their daytime ambulant, rapid fatigue appearance on 
performance of low physical activity and activity of daily 
living dependency; (b) inability to travel independently 
to the rehabilitation center; (c) cognitive disturbances 
that may interfere with participation in the rehabilitation 
program; and (d) serious psychopathology or emotional 
instability that may impede participation in the rehabili-
tation program.
Design
A pre–post test design was used to examine the effects of 
a multidimensional rehabilitation program on fatigue. 
The design allowed us to examine concurrent predictors 
of fatigue and, more importantly, to investigate whether 
change in fatigue over time was associated with change in 
predictors.
Procedures
All patients gave written informed consent to participate 
in the study and for the acquisition of medical information 
from their hospital charts. Medical data were verified by 
record linkage with the population-based cancer registry 
of the Comprehensive Cancer Center North-Netherlands 
(CCCNN). The Medical Ethics Committee of the Univer-
sity Medical Center Groningen approved the study.
After being referred to the study, patients were consec-
utively enrolled in groups of 8–12 patients. Then, an infor-
mation session, including a video session, was organized to 
inform patients about the content of the four components of 
the multidimensional rehabilitation program.
Setting/Intervention
The 15-week program was offered at the Center for Reha-
bilitation of the University Medical Center Groningen in 
an outpatient setting. The choice for a multidimensional 
program was based on the acknowledgment of fatigue as a 
multidimensional construct [33]. The entire rehabilitation 
program consisted of (a) individual exercise, (b) sports, (c) 
psychoeducation, and (d) information (Fig. 1). Participants 
were urged to be present at all sessions. According to the 
session leaders, absence was negligible.
Individual Exercise
The exercise program consisted of 15 sessions of 1.5 hours 
each and was supervised by a physical therapist. The exer-
cise program was divided into an aerobic bicycle training 
and a muscle force training program. The bicycle training 
was performed at a trainings heart rate (THR) of HRrest 
+ 50%–60% (HRmax − HRrest) during weeks 1–3 and at 
a THR of HRrest + 70%–80% (HRmax − HRrest) during 
weeks 4–9 [34]. General muscle force training of trunk and 
lower and upper extremities was performed and based on 
the individual 1-repetition maximum (1-RM) [35]. Individ-
ual intensity of muscle force training started at 50% of the 
1-RM during the first week and was increased by 5%–10% 
during the following weeks with a frequency of 12 rep-
etitions over three series. The rationale to include aerobic 
exercise training and muscle force training in the program 
is that it may mitigate fatigue because of physiological 
improvements [36].
Sports
The sports program consisted of 17 sessions of 1 hour each. 
The sessions were supervised by a physical therapist and 
were directed toward “enjoying sports,” “self-confidence,” 
and “body knowledge.” During the performance of a diver-
sity of sports activities, patients were instructed to become 
aware of physical sensations or limitations so they would 
recognize and respect limitations when performing sports 
or recreational activities at home. Sports were included 
in the program to stimulate patients to perform and enjoy 
sports and, consequently, to increase their level of activity 
in leisure times so that they may break through the vicious 
circle of a low activity pattern, muscle deconditioning, and 
fatigue [16, 17].
Figure 1. The content and frequency of the program components. Abbreviation: I.E, Individual Exercise; Sp, Sports; PE, Psycho-education; 
Inf, Information.
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Psychoeducation
The psychoeducational program consisted of nine sessions 
of 2 hours each. The aims of the psychoeducational program 
were to reduce negative emotions, improve coping with the 
disease, and learn effective stress management techniques 
that may reduce fatigue [22]. A psychosocial specialist with 
several years of experience in conducting group sessions 
with cancer survivors led the psychoeducational program. 
Over several sessions, expressive–supportive techniques, 
breathing exercises, relaxation exercises, and exercises 
from Rational-Emotive Therapy were used to provide 
patients with stress-management techniques.
Information
The information program consisted of 10 sessions of 
1 hour each. The aim of this program was to reduce the 
uncertainty resulting from a lack of knowledge of the 
disease by providing information with respect to cancer-
related subjects. Better knowledge about cancer and can-
cer-related fatigue may lead to a better understanding of 
fatigue as a cancer treatment–related symptom, to change 
of irrational illness perceptions [37], and to the adoption 
of management strategies [22].
Measures
Demographic Variables
Age and gender were assessed.
Disease- and Treatment-Related Variables
Diagnosis, stage of disease, time since diagnosis, type of 
treatment received, and time since end of treatment were 
recorded from the patient’s medical record.
Fatigue
Fatigue was measured with the Multidimensional Fatigue 
Inventory (MFI), which measures the following five dimen-
sions: general fatigue, physical fatigue, reduced activity, 
reduced motivation, and mental fatigue [10]. Every dimen-
sion contains four items and answers are given on a 5-point 
Likert-type scale. Scores have a range of 4–20, and a higher 
score reflects a greater sense of fatigue. Chronbach’s α of 
the present study ranged from 0.71–0.83.
Body Composition
Besides body weight and height, lean body mass (LBM) and 
body fat (BF) were assessed by bioelectrical impedance anal-
yses (Bodystat®1500, Douglas, Isle of Man, British Islands). 
Bioelectrical impedance measures resistance, LBM, and 
BF with a frequency of 50 kHz, using empirically-derived 
formulas. Measurements were taken with the patient in the 
supine position at the right side with electrodes on the third 
metacarpal bone, wrist, the second metatarsal bone, and 
the dorsum of the ankle. Patients were asked to refrain from 
ingesting food or beverages prior to the measurement. Body 
Mass Index (BMI) is calculated as weight (kg)/height (m2). 
BMI has been used in evaluating cachexia and obesity. The 
normal range proposed by the World Health Organization 
(WHO) is 18.5–24.9 kg/m2.
Physiological Functioning
Exercise capacity. A symptom-limited bicycle ergome-
try test was performed using a ramp 10, 15, or 20 protocol, 
depending on the patient’s fitness. The load was increased 
every minute by 10, 15, or 20 Watts, respectively, in such 
a way that patients could reach their maximal workload 
within 10 minutes. The test was terminated on the basis of 
the patient’s symptoms or at the physician’s discretion [38]. 
Maximal workload in Watts at maximal performance was 
taken for analysis.
Muscle force. Maximal voluntary isometric muscle 
force of the right and left extremity of the following muscle 
groups was measured: extension of the knee, flexion of the 
elbow, and extension of the elbow, using a handheld dyna-
mometer (Force Evaluating & Testing (microFET), Hog-
gan Health Industries Inc, West Jordan, UT). The “break 
method” was used for all measurements. To use this tech-
nique, the examiner gradually overcomes the force pro-
duced by the patient until the extremity gives way [39]. All 
measurements were performed at least three times with 
recovery intervals of at least 10 seconds. Peak forces (in 
Newtons) were recorded and mean values of three techni-
cally correct measurements were taken for analysis.
Physical Symptoms and Psychological Distress
The Rotterdam Symptom Check List, a self-report ques-
tionnaire, was used to assess disease-related quality of 
life. The checklist contains 23 items for physical symp-
tom distress and seven items for psychological distress. 
Responses are presented on a 4-point Likert-type scale. 
A higher score reflects a higher level of burden of impair-
ment. Normal scores for the general population are avail-
able [40]. Chronbach’s α for the present study ranged from 
0.67–0.87.
Perceived Physical Functioning, Mental Functioning, 
and Role Limitations
Three subscales, Physical Functioning (10 items), Role 
Limitations due to physical problems (four items), and 
Mental Health (five items), of the RAND-36, which is a 
multidimensional self-report questionnaire, were used to 
assess global health-related quality of life. After recoding 
188 Cancer-Related Fatigue
TheOncologist®
and transformation, scores range from 0–100, and a higher 
score represents better health. Normal scores for the gen-
eral population are available [41]. Chronbach’s α for the 
present study ranged from 0.84–0.85.
Self-Efficacy
The feeling of competence or having control over one’s 
life was measured with the ALCOS (16 items), which is 
the Dutch version of the General-Self-Efficacy Scale [42]. 
Responses are presented on a 5-point Likert-type scale. A 
higher score reflects a higher level of self-efficacy. Crohn-
bach’s α for the present study was 0.82.
Data Analyses
Descriptive statistics were used to describe the study 
population. Paired t-tests were used to assess differences 
between the two measurement times, T0 and T1. The effect 
size (ES) and threshold at the 5% level were calculated as 
indices measuring the magnitude of a treatment effect [43]. 
Middel et al. [44] showed that ES reflects clinical relevance. 
An ES <0.20 indicates “no change,” an ES ≥0.20 but <0.50 
indicates "a small change," an ES ≥0.50 but <0.80 indicates 
"a moderate change," and an ES ≥0.80 indicates "a consid-
erable change."
To examine the effects of the different predictor variables 
on fatigue at baseline, the following analyses were performed. 
First, univariate relationships between MFI dimensions on 
the one hand and demographic variables, disease- and treat-
ment-related variables, body composition, physiological 
variables, physical and psychological symptoms, and per-
ceived functioning on the other hand were examined using 
Pearson’s correlation analyses. In cases of dichotomous 
variables, differences were assessed by independent t-tests. 
Analysis of variance (ANOVA) was used to assess differ-
ences between treatment groups. Second, to investigate the 
main determinants of fatigue at baseline, variables signifi-
cantly related to a subscale of the MFI were entered into a 
multiple regression model and analyzed stepwise. Five sepa-
rate multiple regression analyses were performed, a separate 
one for each fatigue subscale. For nominal variables (treat-
ment, diagnosis), we created dummy variables.
To examine whether change in fatigue was associated 
with change in baseline predictors, we performed five sepa-
rate hierarchical multiple regression analyses. The sub-
scales of fatigue postintervention were the dependent vari-
ables in the five regression models. The effect of fatigue at 
baseline (T0) on subsequent fatigue (T1) was first entered 
to control for earlier levels of fatigue. In the second step, the 
difference (Δ) between a predictor variable score at base-
line (T0) and a subsequent predictor variable score (T1) was 
entered into the regression model. These analyses allow the 
examination of associations between change in fatigue and 
change in physical or psychological variables. Only those 
predictor variables that had a significant unique effect on 
preintervention fatigue were entered into the models.
Correlational analyses between the independent vari-
ables and variance inflation factors (VIF = 1/1 − R2) were 
calculated to assess multicollinearity. Multicollinearity is 
present if the mean VIF is considerably larger than one and 
the largest VIF is greater than 10 [45].
Results
Patient Characteristics
Seventy-two patients entered the program. Fifteen percent 
of the participants were male. The mean (standard deviation 
[SD]) age of the participants was 51.4 (9.6) years. Sixty-one 
percent of the patients were women with breast cancer, and 
39% had other cancer diagnoses. Two thirds of the patients 
had stage I or stage II disease. Two thirds of the participants 
had completed treatment during the preceding year (Table 
1). The most often reported indication for referral to the reha-
bilitation program was fatigue. Fifty-six patients (77.8%) 
completed the program and the questionnaires: 10 patients 
developed cancer recurrence and dropped out of the program 
of their own volition. A further six patients left the program: 
for personal reasons (two patients), because of malaise (two 
patients), and for unknown reasons (two patients). Dropout 
was therefore 22.3%. χ2 tests and t-tests revealed no signifi-
cant differences between dropouts and those that stayed in 
with respect to gender, age, cancer diagnosis, time since 
diagnosis, time since completion of treatment, and fatigue 
at T0. χ2 tests revealed significantly more cancer recurrences 
in the dropout group than in the stay-in group (p < .001).
Effects of the Multidimensional Rehabilitation 
Program on the Different Dimensions 
of Cancer-Related Fatigue
Paired t-tests of mean scores at T0 and T1 showed that 
patients reported significant improvements in every 
domain of the MFI after the cancer rehabilitation program 
(Table 2). The ES of T0 and T1 with respect to fatigue after 
the intervention varied from −0.35 (small change) to −0.78 
(moderate change).
Mann-Whitney tests were performed to examine the 
effect of time since completion of treatment. The choice 
for this test was made because the distribution of time since 
completion was skewed; categorization was based on the 
median of 6.7 months. No significant differences were 
found between patients with a time since completion of 
treatment shorter than 6.7 months and patients with a longer 
time in any domain of fatigue before and after the program.
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Table 1. Patient characteristics at time of inclusion (T0), n = 72
n %
Physician-reported indication criteria for rehabilitation (yes)
 Physical complaints



















 Non-Hodgkin’s lymphoma/Hodgkin’s disease
 Gynecological cancer































Cancer treatment before rehabilitation
 Chemotherapy with/without surgery
 Radiotherapy with/without surgery
 Combination (chemotherapy and radiotherapy) with/without surgery
 Surgery





























 Weight, mean (SD) in kg
 Height, mean (SD) in cm
 BMI, mean (SD) in kg/m2
 Lean body mass, mean (SD) in kg













Age, mean (SD) years
Gender, male: female, n (%)
51.4 (9.6)
11 (15.3): 61 (84.7)
Abbreviations: BMI, body mass index; SD, standard deviation.
Table 2. Descriptives and comparison of Multidimensional Fatigue Inventory scores between patients before (T0) and after (T1) 







Mean (SD) t Effect size
95%
CI for ES
General fatigue 15.0 (3.9) 12.9 (4.7)a 4.51 −0.48 −0.86 to −0.11
Physical fatigue 14.9 (4.2) 11.6 (4.2)a 7.17 −0.78 −1.16 to −0.40
Reduced activity 12.9 (4.0) 10.7 (4.1)a 4.22 −0.54  −0.92 to −0.16
Reduced motivation 10.4 (3.7) 09.1 (3.6)b 3.26 −0.35  −0.73 to −0.02
Mental fatigue 13.2 (4.1) 11.7 (4.2)b 2.98 −0.36  −0.73 to −0.01
ap < .001; bp < .01.
Abbreviations: SD, standard deviation.
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Main Predictors of Cancer-Related Fatigue 
in Patients Referred to a Cancer 
Rehabilitation Program
Correlational analyses between the predictor variables 
showed low to moderate coefficients ranging from 0.27 
(physical functioning and mental functioning) to 0.74 (men-
tal functioning and psychological distress).
MFI– General Fatigue
ANOVA showed that patients who had received radiother-
apy combined with surgery had higher scores on general 
fatigue at baseline than those who had received chemo-
therapy or combined therapy with surgery. Correlational 
analyses showed that general fatigue at baseline was nega-
tively associated with maximal workload, muscle force 
of lower extremity, physical functioning, role limitations, 
and psychological functioning. General fatigue appeared 
positively related to physical symptom distress and psy-
chological distress (Table 3). Multiple stepwise regression 
analysis showed that physical functioning was the stron-
gest predictor, followed by radiotherapy (with surgery) 
and physical symptom distress. Total variance explained 
was 48.8% (Table 4). VIFs ranged from 1.0–1.69.
MFI–Physical Fatigue
Physical fatigue at baseline appeared to be negatively 
associated with maximal workload, muscle force of upper 
extremity and lower extremity, physical functioning, role 
Table 3. Fatigue at baseline: independent t-tests and analysis of variance of demographic characteristics and disease and treat-
ment-related variables, and Pearson correlational analyses of  physiological variables , symptom distress, and perceived func-
tioning and the different sub-scales of fatigue pre intervention, n=72. 
General 
Fatigue
F                  r
Physical 
Fatigue
t                  r
Reduced 
Activity
t                  r 
Reduced 
Motivation
t                  r
Mental 
Fatigue
t                  r    
Demographic variables  
Age
Gender (female = 1, male = 0)
 .28a .26a
Disease and treatment-related variables
Diagnosis (breast cancer = 1, other = 0)
Type of treatment 
- Chemotherapy with surgery
- Radiotherapy with surgery 
- Combined therapy with surgery
Time since diagnosis





Physiological variables  
 Maximal workload
Muscle force upper extremity




















Perceived  functioning variables
Physical functioning (Rand-36)
Mental health (Rand-36)





















Only significant relationships are depicted. 
a p<.05, b p<.01, c p<.001.
Abbreviations: RSCL, Rotterdam Symptom Check List.
van Weert, Hoekstra-Weebers, Otter et al.    191
www.TheOncologist.com
limitations, psychological functioning, and self-efficacy. 
Physical fatigue appeared to be positively related to physi-
cal symptom distress (Table 3). Multiple stepwise regres-
sion analysis showed that role limitation due to physical 
problems was the strongest predictor, followed by maximal 
workload. Total variance explained was 54.6% (Table 4). 
VIFs ranged from 1.02–2.03.
MFI–Reduced Activity
Reduced activity at baseline was negatively associated with 
maximal workload, role limitations, psychological func-
tioning, and self-efficacy. Reduced activity appeared posi-
tively related to age (Table 3). Multiple stepwise regression 
analysis showed that role limitation due to physical prob-
lems was the strongest predictor of reduced activity at base-
line, followed by psychological functioning. Total variance 
explained was 26.2% (Table 4). VIFs ranged from 1.0–1.84.
MFI–Reduced Motivation
Reduced motivation at baseline was negatively associated 
with maximal workload, muscle force of lower extremity, 
physical functioning, role functioning, psychological func-
tioning, and self-efficacy. Reduced motivation appeared 
positively associated with age, physical symptom distress, 
and psychological distress (Table 3). Multiple stepwise 
regression analysis showed that self-efficacy was the stron-
gest predictor, followed by physical functioning and age. 
Total variance explained was 38.7% (Table 4). VIFs ranged 
from 1.0–1.99.
MFI–Mental Fatigue
Mental fatigue at baseline was negatively associated with 
physical functioning, role limitations, psychological func-
tioning, and self-efficacy. Mental fatigue appeared posi-
tively related to physical symptom distress and psychologi-
cal distress (Table 3). Multiple stepwise regression analysis 
showed that physical symptom distress was the only signifi-
cant predictor of mental fatigue at baseline. Total variance 
explained was 25.4% (Table 4). VIFs ranged from 1.0–1.29.
Posthoc analyses revealed that female patients had a lower 
LBM and a higher percentage BF than male patients (p = 
<.001). LBM was significantly correlated with muscle 
force (r = 0.46; p < .001), but not associated with any of the 
domains of fatigue.













Disease- and treatment-related variables
Type of treatment (radiotherapy with
surgery, 1; other, 0)
0.36b
Physiological variables
Maximal workload −0.001 −0.40b −0.07  0.07
Muscle force upper extremity  0.03
Muscle force lower extremity −0.03  0.02  0.04
Symptom distress variables
Physical symptoms (RSCL)  0.27a  0.13  0.01  0.50c 
Psychological symptoms (RSCL)  0.16  0.06  0.14
Perceived functioning
Physical functioning (RAND-36) −0.40b −0.20 −0.27a −0.13
Psychological functioning (RAND-36) −0.11 −0.14 −0.23a −0.15 −0.09
Role limitations physical problems 
(RAND-36)
−0.12 −0.44c −0.40b −0.10 −0.13
Self-efficacy (ALCOS) −0.06 −0.10 −0.40b −0.11
Total R2 48.8% 54.6% 26.2% 38.7% 25.4%
Only variables entered into the model are depicted.
ap < .05; bp < .01; cp < .001.
Abbreviations: RSCL, Rotterdam Symptom Check List.
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Associations Between Change in Fatigue Following 
the Rehabilitation Program and Change in Predic-
tors Identified as Having an Independent Effect on 
Fatigue at Baseline (Table 5)
MFI–Change in General Fatigue
General fatigue at baseline accounted for 46% of the vari-
ance in fatigue postintervention (step 1). The variables 
entered into the second step accounted for a significant 
increment of 7%. Change in physical functioning had sig-
nificant unique effects, but change in physical symptom 
distress did not. Thus, decreased general fatigue was asso-
ciated with better physical functioning. Total variance 
explained was 53%. VIFs ranged from 1.0–1.08.
MFI–Change in Physical Fatigue
Physical fatigue at baseline accounted for 41% of the vari-
ance in fatigue postintervention. The variables entered into 
the second step accounted for a significant increment of 17%. 
Change in role limitations due to physical problems had a sig-
nificant unique effect, but change in maximal workload did 
not. (Assessment of maximal workload was not possible in 12 
patients due to mechanical breakdown of the apparatus [3], 
nausea [2], claustrophobia [1], or perceived irrelevance, pain-
fulness, discomfort, or strenuousness of the test [6]. Conse-
quently, the analysis examining change in physical fatigue 
was performed on 44 patients.) Thus, decreased physical 
fatigue was associated with fewer role limitations. Total vari-
ance explained was 58%. VIFs ranged from 1.0–1.3.
MFI–Change in Reduced Activity
Reduced activity at baseline accounted for 38% of the vari-
ance in fatigue postintervention. The variables entered into 
the second step accounted for a significant increment of 
11%. Change in role limitations due to physical problems 
and change in psychological functioning appeared to have a 
significant unique effect. Thus, a decrease in reduced activ-
ity was associated with fewer role limitations and better 
psychological functioning. Total variance explained was 
49%. VIFs ranged from 1.0–1.01.
MFI–Change in Reduced Motivation
Reduced motivation at baseline accounted for 44% of the 
variance in fatigue postintervention. The variables entered 
in the second step accounted for a significant increment 
of 8%. Change in physical functioning had a significant 
unique effect, but change in self-efficacy did not. Thus, a 
decrease in reduced motivation was associated with better 
physical functioning. Total variance explained was 52%. 
VIFs ranged from 1.0–1.02.
MFI–Change in Mental Fatigue
Mental fatigue at baseline accounted for 36% of the vari-
ance in fatigue postintervention. Change in physical symp-
tom distress entered in the second step accounted for a 
significant increment of 6%. Thus, decreased fatigue was 
associated with reduced physical symptom distress. Total 
variance explained was 42%. VIFs were all 1.0.












β  R2ch Fch    p β  R2ch Fch   p β R2ch Fch   p β R2ch Fch    p β R2ch Fch   p
Step 1
    Fatigue preintervention (T0)
Step 2
    Physiological variables
ΔMaximal workload
ΔMuscle force upper extremity
ΔMuscle force lower extremity
    Symptom distress variables
ΔPhysical symptoms
ΔPsychological symptoms
    Perceived functioning
ΔPhysical functioning
ΔPsychological functioning
ΔRole limitations physical 
problems
ΔSelf-efficacy
 .46  46.3 <.001
.68c
 .07  3.8  <.05
.08
−.23a
 .41 26.9 <.001
0.64c
 17  7.1  <.001
−.02
−.42c
 .38 31.2 <.001
.62c
 .11  5.1  <.01
−.25a
−.21a
 .44  42.3 <.001
.67c
 .08  4.2  <.01
−.27b
−.06 
 .36  30.0 <.001
.60c
 .06  5.6  <.01
.25a
Total R2 (%) 53% 58% 49% 52% 42%
ap < .05; bp < .01; cp < .001.
Δ, difference between T0 and T1.
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Discussion
The present study assessed fatigue multidimensionally in 
a selected group of cancer patients referred to a rehabilita-
tion program. Within this group of patients, we found that 
(a) rehabilitation is effective in reducing fatigue, (c) both 
physical and psychological parameters predicted different 
dimensions of fatigue, and (c) change in fatigue is mainly 
associated with change in physical parameters.
The first aim of the study was to assess the effects of 
a multidimensional rehabilitation program on cancer-
related fatigue, a program of which the beneficial effects 
on quality of life have recently been reported [46]. The 
results of the present study showed that patients reported 
statistically significant and, more importantly, clinically 
relevant reductions in cancer-related fatigue after comple-
tion of the multidimensional program. Most reductions 
in fatigue were found in the domain of physical fatigue. 
One could argue that the effect found was due to matura-
tion [47] rather than to the intervention. However, patients 
were eligible for the rehabilitation program only when 
(a) treatment had been completed at least 3 months prior 
to rehabilitation so that patients had time to naturally 
recover from cancer-related treatment effects and (b) the 
physician had judged that the presence of physical and 
psychological problems were persisting. In addition, the 
finding that there were no associations between time since 
completion of treatment and fatigue before and after the 
program argues against a maturation effect. This suggests 
that the beneficial effects on fatigue could be attributed to 
the intervention.
The second aim of the study was to examine the contri-
bution of different variables to the determination of can-
cer-related fatigue reported by patients referred to a cancer 
rehabilitation program. Our study showed that gender was 
not a significant determinant of fatigue at baseline. Other 
studies reported that women suffer more from fatigue than 
men do [48]. We did not observe such a relationship per-
haps because of the low number of men in our study. With 
respect to age, we found that age was not associated with 
any domain of fatigue except a greater reduction in moti-
vation. This finding is in accordance with several other 
studies reporting no relationship between age and fatigue 
in cancer patients. However, it is in contrast to studies in 
the normal population reporting more fatigue in older 
people [48, 49]. With respect to disease- and treatment-
related factors, we found no associations between type of 
cancer, time since diagnosis or completion of treatment, 
or type of treatment received and the different domains 
of fatigue, except that those who had undergone radio-
therapy with surgery reported more fatigue than those 
who had received chemotherapy with surgery or a combi-
nation of chemotherapy, radiotherapy, and surgery. LBM 
and BF percentage appeared not to be related to any of the 
domains of fatigue.
Correlational analyses of the baseline data showed that 
the different dimensions of fatigue at baseline were associ-
ated with different physical and psychological parameters, 
supporting the notion that cancer-related fatigue is a mul-
tidimensional construct in nature. Regression analyses 
showed that maximal workload, physical symptoms, per-
ceived physical functioning, psychological functioning, 
role limitations due to physical problems, and self-efficacy 
were the main determinants of fatigue at baseline.
The findings that physical and psychological param-
eters are predictive of fatigue are in agreement with our sec-
ond hypotheses and are in accordance with earlier studies 
of cancer patients [50–52]. In addition, our results support 
the notion [51] that it is important to systematically assess 
and manage both physical and psychological symptoms of 
cancer-related fatigue.
An interesting finding was that physical fatigue was 
determined by maximal workload. Other authors used the 
6- or 12-minute walk test [53] to assess exercise capacity. 
However, those authors did not statistically examine the 
relationship between fatigue and the 6- or 12-minute walk 
test. Furthermore, the 6- and 12-minute walk test has the 
disadvantage that it is a self-paced and submaximal test 
[54] that reflects more general functional ability [53] rather 
than genuine exercise capacity. The extra value of our study 
is that we included bicycle ergometry with a protocol that 
forced patients to maximal performance, which has been 
reported to be a more adequate measure of maximal exer-
cise capacity [38, 55].
Furthermore, we found that self-efficacy was a sig-
nificant predictor of reduced motivation only. Appar-
ently, self-efficacy seems to be a less important variable 
in cancer patients than has been suggested in studies of 
chronic fatigue syndrome [50] and rheumatoid arthri-
tis [56], which indicate that patients with a lower self-
efficacy perceive more fatigue in general. In addition, 
baseline results revealed that mental fatigue was not 
determined by psychological variables but by physical 
symptom distress only, indicating that patients with a 
high level of physical symptom distress experienced 
more mental fatigue.
The proportion of the variance of fatigue at baseline 
explained by the variables included in the regression 
models varied from 25.4%–54.6%. The proportion of 
variance explained in the domains general fatigue and 
physical fatigue was higher than that in the domains 
of reduced motivation, reduced activity, and mental 
fatigue. Apparently, the variables included in our study 
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were more relevant in predicting the more physical areas 
of fatigue than the more ‘psychologically’ oriented areas 
of fatigue.
The results regarding the associations between change 
in fatigue and change in physical and psychological vari-
ables revealed that fatigue at baseline was the most power-
ful predictor. This finding is in line with an earlier study 
showing that fatigue after radiation was mainly determined 
by fatigue prior to radiation [10].
A further finding of the study was that a decrease in the 
different dimensions of fatigue was mainly associated with 
improvements in physical parameters, including a decrease 
in physical symptoms and an improvement in perceived 
physical functioning and perceived role limitations due to 
physical problems. These findings are partly in agreement 
with our second hypothesis.
Change in physical and, to a lesser degree, psychologi-
cal variables accounted for a significant but small incre-
ment (6%–17%) in the prediction, suggesting that other 
variables not included in the present study may be more 
relevant and should be taken into account in future studies. 
Possible suggestions are personality characteristics, social 
support, pain, and quality of sleep.
Although the predictive power of change in physical and 
psychological variables is relatively small, such change may 
be clinically important. Any alleviation of fatigue induced 
by cancer rehabilitation may be relevant for patients, con-
sidering the 20%–40% of patients who continue to suffer 
from fatigue long after cancer treatment. Furthermore, 
there may be an additional indirect effect of the program, 
that is, that patients with less fatigue may have more poten-
tial to break through the vicious circle of inactivity, muscle 
deconditioning, and fatigue.
The question of which component of the presented 
rehabilitation intervention may have accounted for the 
results is difficult to answer on the basis of the present 
study design. It is not possible to compare the effects of 
the physical or psychological components separately. 
However, the finding that change in fatigue was predomi-
nantly associated with change in physical parameters may 
suggest that a program consisting only of physical compo-
nents might be effective enough.
The results may further suggest that future research 
should examine whether early screening of cancer-
related fatigue, suggested to take place at the patient's 
initial contact with an oncologist [22], is feasible and 
effective in fatigue management and health-related qual-
ity of life.
Study Limitations and Clinical and Research 
Implications
With respect to the longitudinal design of the present study, 
the following remarks can be made. The interpretation of the 
results with respect to the effectiveness of the program should 
be made with caution because we did not include a control 
group. However, changes found in our study were not only 
statistically significant, but also appeared to be clinically rel-
evant. In addition, the achieved beneficial effects on fatigue 
may be attributed to genuine effects of the intervention, 
regarding the long natural recovery time in most of the referred 
patients. In further research, a prospective randomized con-
trolled study including a physical intervention, a psychologi-
cal intervention, and/or a combined intervention seems to be 
necessary to examine the effects more thoroughly.
The strength of the longitudinal study design is that 
we were not only able to determine predictors of fatigue 
at baseline, but were also able to determine that change in 
fatigue was predominantly associated with change in phys-
ical parameters.
Multicollinearity between the independent variables may 
be a point of concern with respect to the regression models of 
fatigue. However, correlation analyses ranging from low to 
moderate and the low VIFs show that multicollinearity does 
not seem to be a point of concern in this study.
Conclusion
Different dimensions of fatigue at baseline are associ-
ated with different physical and psychological symptom 
parameters, suggesting that cancer-related fatigue is a mul-
tidimensional construct in nature. The multidimensional 
rehabilitation program presented in the current study had 
statistically and clinically relevant and positive effects on 
cancer-related fatigue. Decreases in fatigue were found to 
be predominantly associated with beneficial changes in 
physical parameters such as a decrease in physical symp-
toms and an improvement in perceived physical (role) func-
tioning. The results suggest that future interventions should 
at least include a physical training/sport component to 
reduce fatigue in cancer patients.
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